252 related articles for article (PubMed ID: 30867003)
1. Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer.
Xiong Y; He L; Shay C; Lang L; Loveless J; Yu J; Chemmalakuzhy R; Jiang H; Liu M; Teng Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):122. PubMed ID: 30867003
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Accumulation of Heat-shock Protein 90 Is Associated with Poor Survival and Metastasis in Patients with Non-small Cell Lung Cancer.
Su JM; Hsu YY; Lin P; Chang H
Anticancer Res; 2016 May; 36(5):2197-203. PubMed ID: 27127123
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of 14-3-3γ Suppresses Epithelial-Mesenchymal Transition and Reduces Metastatic Potential of Human Non-small Cell Lung Cancer Cells.
Raungrut P; Wongkotsila A; Champoochana N; Lirdprapamongkol K; Svasti J; Thongsuksai P
Anticancer Res; 2018 Jun; 38(6):3507-3514. PubMed ID: 29848704
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
6. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M
J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888
[TBL] [Abstract][Full Text] [Related]
7. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z
BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer.
Wang Y; Dong Q; Miao Y; Fu L; Lin X; Wang E
Lung Cancer; 2013 Aug; 81(2):266-72. PubMed ID: 23711689
[TBL] [Abstract][Full Text] [Related]
9. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Liu H; Gu Y; Wang H; Yin J; Zheng G; Zhang Z; Lu M; Wang C; He Z
Oncotarget; 2015 Jun; 6(17):14913-25. PubMed ID: 25945834
[TBL] [Abstract][Full Text] [Related]
11. [Hsp90AB1 Protein is Overexpressed in Non-small Cell Lung Cancer Tissues
and Associated with Poor Prognosis in Lung Adenocarcinoma Patients].
Wang M; Feng L; Li P; Han N; Gao Y; Xiao T
Zhongguo Fei Ai Za Zhi; 2016 Feb; 19(2):64-9. PubMed ID: 26903158
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
Tung CL; Chiu HC; Jian YJ; Jian YT; Chen CY; Syu JJ; Wo TY; Huang YJ; Tseng SC; Lin YW
Exp Cell Res; 2014 Apr; 322(2):345-54. PubMed ID: 24530475
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer.
Guan ZB; Cao YS; Li Y; Tong WN; Zhuo AS
Cancer Biomark; 2018 Feb; 21(3):557-563. PubMed ID: 29286919
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X
Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679
[TBL] [Abstract][Full Text] [Related]
15. Placental growth factor promotes metastases of non-small cell lung cancer through MMP9.
Zhang W; Zhang T; Lou Y; Yan B; Cui S; Jiang L; Han B
Cell Physiol Biochem; 2015; 37(3):1210-8. PubMed ID: 26418253
[TBL] [Abstract][Full Text] [Related]
16. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
[TBL] [Abstract][Full Text] [Related]
17. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
[TBL] [Abstract][Full Text] [Related]
18. LncRNA BCAR4 promotes proliferation, invasion and metastasis of non-small cell lung cancer cells by affecting epithelial-mesenchymal transition.
Li N; Gao WJ; Liu NS
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2075-2086. PubMed ID: 28537678
[TBL] [Abstract][Full Text] [Related]
19. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]